Skip to content

13F-HR filed by Euclidean Capital LLC

Euclidean Capital LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 11 holding rows worth $237,998,579.

Accession
0001012975-25-000761
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 11 entries on the cover page, a total value of $237,998,579 stated on the cover page (in dollars after the unit check, H1), rows summing to $237,998,579 with VALUE read as dollars as filed, 13F file number 028-20777. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Vanguard FTSE All-World ex-US ETF922042775SHS2,578,184$184,004,992dollars as filed
ISHARES TR46429B598MSCI INDIA ETF369,600$19,241,376dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM989,410$11,872,920dollars as filed
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,573,761$7,695,691dollars as filed
ALECTOR INC014442107COMMON STOCK1,307,858$3,871,260dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM2,627,643$3,678,700dollars as filed
SPY78462F103SHS4,104$2,734,003dollars as filed
RAPT THERAPEUTICS INC75382E208COM NEW82,234$2,120,815dollars as filed
TENAYA THERAPEUTICS INC87990A106COM1,015,705$1,645,442dollars as filed
SURROZEN INC86889P208COMMON STOCK87,696$1,129,963dollars as filed
SURROZEN INC86889P117*W EXP 08/01/203170,833$3,417dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-25-000761this filing2025-11-14acceptance time not in the bulk data set